LeMaitre (LMAT) Reports Q2: Everything You Need To Know Ahead Of Earnings

Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Tuesday after market close. Here’s what to expect.

LeMaitre beat analysts’ revenue expectations by 3.7% last quarter, reporting revenues of $59.87 million, up 12% year on year. It was a satisfactory quarter for the company, with an impressive beat of analysts’ organic revenue estimates but a miss of analysts’ EPS estimates.

Is LeMaitre a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting LeMaitre’s revenue to grow 12.1% year on year to $62.58 million, in line with the 11.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.57 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. LeMaitre has missed Wall Street’s revenue estimates three times over the last two years.

Looking at LeMaitre’s peers in the surgical equipment & consumables - specialty segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Teleflex delivered year-on-year revenue growth of 2.3%, beating analysts’ expectations by 1.3%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Teleflex traded up 1.7% following the results while Intuitive Surgical was down 1.9%.

Read our full analysis of Teleflex’s results here and Intuitive Surgical’s results here.

Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the surgical equipment & consumables - specialty stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. LeMaitre is down 2.3% during the same time and is heading into earnings with an average analyst price target of $104.50 (compared to the current share price of $81.04).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.